SCHEMBL4507329

SCHEMBL4507329

O=C(OCc1ccccc1)N(CCO)c1ccc(Br)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
HPGD P15428 3/20 0.47
MAPT P10636 2/20 0.47
KDM4E B2RXH2 2/20 0.47
CCR6 P51684 1/20 0.44
PAX8 Q06710 1/20 0.44
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
FABP7 O15540 1/20 0.41
FABP5 Q01469 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
MAPK1 P28482 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12311314 0.90 PAX8 (0.49) ALDH1A1HPGDMAPTCCR6PAX8
SCHEMBL4021063 0.88 ALDH1A1 (0.46) ALDH1A1HPGDMAPTKDM4ECCR6
SCHEMBL10126799 0.86 ALDH1A1 (0.49) ALDH1A1HPGDMAPTKDM4ECCR6
SCHEMBL28394951 0.84 ALDH1A1 (0.51) ALDH1A1HPGDMAPTKDM4EFABP7
SCHEMBL12311342 0.77 ALDH1A1 (0.50) ALDH1A1HPGDMAPTCCR6PAX8
SCHEMBL3084308 0.77 ALDH1A1 (0.50) ALDH1A1HPGDMAPTCCR6PAX8
SCHEMBL12311311 0.76 ALDH1A1 (0.45) ALDH1A1HPGDMAPTCCR6PAX8
SCHEMBL554069 0.76 CCR6 (0.64) ALDH1A1HPGDMAPTCCR6PAX8
SCHEMBL15841147 0.74 CCR6 (0.62) ALDH1A1HPGDMAPTCCR6PAX8
SCHEMBL28394950 0.73 ALDH1A1 (0.52) ALDH1A1PAX8L3MBTL1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632851-B2 Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers NOVARTIS AG (CH) 2009-12-15 US disclosed
US-20060093551-A1 Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers NOVARTIS AG (CH) 2006-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060093551-A1 Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers H1-3, MKI67, H1-5 ALDH1A1 551/4885HPGD 410/4885MAPT 2136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.